Production (Stage)
D
Oruka Therapeutics, Inc. ORKA
$12.58 $0.393.20% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025
Total Cash And Short-Term Investments 1,158.31%
Total Receivables --
Inventory --
Prepaid Expenses --
Finance Division Loans and Leases Current --
Total Finance Division Other Current Assets --
Other Current Assets --
Total Current Assets 1,169.09%

Total Current Assets 1,169.09%
Net Property, Plant & Equipment --
Long-term Investments --
Goodwill --
Total Other Intangibles --
Finance Div Loans & Leases LT --
Total Finance Div Other LT Assets --
Total Other Assets -78.89%
Total Assets 1,235.81%

Total Accounts Payable 88,525.00%
Total Accrued Expenses -7.92%
Short-term Debt --
Current Portion of Long-Term Debt/Capital Leases --
Finance Division Debt Current --
Total Finance Division Other Current Liabilities 1,041.13%
Total Other Current Liabilities 1,041.13%
Total Current Liabilities 63.61%

Total Current Liabilities 63.61%
Long-Term Debt --
Short-term Debt --
Capital Leases --
Finance Division Debt Non Current --
Total Finance Division Other Non Current Liabilities --
Total Other Liabilities --
Total Liabilities -61.72%

Common Stock & APIC 2,591,694.44%
Retained Earnings -1,379.77%
Treasury Stock & Other --
Total Common Equity 5,225.29%

Preferred Stock Redeemable --
Preferred Stock Non Redeemable --
Preferred Stock Convertible 0.00%
Preferred Stock, Others --
Total Preferred Equity 0.00%

Total Common Equity 5,225.29%
Total Preferred Equity 0.00%
Total Minority Interest --
Total Equity 8,935.39%